Operating portfolio 7,304,971
Repositioning and redevelopment properties 1,676,651
Construction in progress 1,437,000
Total portfolio 10,418,622
Land parcels 1,367,000
Total proforma portfolio 11,785,622
Following the end of the quarter, on October 3, 2008, a portion of the parking spaces at the garage located on the company's Center for Life Science | Boston property were sold for approximately $29.0 million pursuant to an agreement assumed by the company in connection with its acquisition of the property in November 2006.
On October 14, 2008, the company acquired the minority interest in the entity that owns the 530 Fairview Avenue property in Seattle for approximately $2.6 million; as a result, the company owns 100% of the property.
BioMed Realty Trust's board of directors previously declared a third quarter 2008 dividend of $0.335 per share of common stock, and a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from July 16, 2008 through October 15, 2008.
Having reported results for the first nine months of 2008, the company
has narrowed its 2008 earnings guidance. The company has also adjusted its
earnings guidance to reflect the impact of the October 2008 common stock
offering. The company's revised 2008 guidance for net income per diluted
share and FFO per diluted share is set forth and reconciled below.
(Low - High)
Projected net income per diluted
|SOURCE BioMed Realty Trust, Inc.|
Copyright©2008 PR Newswire.
All rights reserved